GIGABYTE
24.2.2020 16:02:10 CET | Business Wire | Press release
GIGABYTE was originally scheduled to exhibit its edge computing products, as well as data center solutions to seize the 5G opportunities at the Mobile World Congress (MWC) held at the end of February. Although the 2020 event is canceled by the GSMA, GIGABYTE made its show into a digital format, [GIGABYTE MWC Online](https://www.gigabyte.com/MWC/2020 ), allowing its partners, customers, and users to still see its latest developments for the 5G era.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200224005042/en/
MWC is the world’s biggest exhibition for the telecommunications industry aimed to highlight how next-generation networks will form the basis of wide-reaching value creation and economic impact in the 5G era. GIGABYTE, being an enabler for digital era businesses to transform their core values seamlessly with the technology trends of tomorrow, wants to take the initiative to showcase its server solutions ready to be used as MEC (Multi-access Edge Computing) platforms to support the new generation of 5G technologies and services, leveraging its innovative hardware design together with NFV (Network Functions Virtualization) and open-source software stacks to meet the QoS requirements of 5G.
On The Edge of 5G
On [GIGABYTE MWC Online], the MEC products and solutions are embedded into an interactive map to illustrate how they fit into 5G scenarios of eMBB , URLLC , and mMTC . GIGABYTE offers one of industry’s most comprehensive server product lineups that can help businesses from different vertical markets to overcome the challenges of building data center infrastructure necessary for success in the 5G era. GIGABYTE’s G591-HS0, featuring support for up to 32 accelerator cards, can provide powerful compute capabilities to build a combined MEC / VR stitching / processing server, which allows for high resolution videos to be processed and stored locally on the baseband unit, therefore making it ideal for enabling live streaming of 8K video or 360 VR at large spectator events. GIGABYTE also launched a 5G CrowdCell with LimeNET, to overcome 5G’s weaknesses of short range and signal drop-offs when hitting concrete walls, further completes the eMBB scenario of next-generation spectator experience. GIGABYTE’s H242-Z10 is a prime example of a compact GPU accelerated edge server platform that can be deployed to connect an intelligent vehicles network in order to overcome performance limitations previously constrained by onboard vehicle processing, or the latency and transmission bottlenecks of cloud computing. Its ultra-small footprint form factor can be mass deployed at scale at the far edge, which is perfect to also be used as an mMTC server to support an IoT network to enable a smart city.
Data Center Know-How for 5G Era
GIGABYTE will establish its vital place in the 5G ecosystem through MEC-optimized server platforms. Moreover, GIGABYTE has long been an exceptional server hardware and solution provider that helps businesses to build the data center infrastructure that can accelerate their innovation in 5G. GIGABYTE’s software-defined storage solution can consolidate existing media and effortlessly add new capacity that supports all main storage types (block, object or file) while simplifying management and reducing infrastructure costs; and GIGABYTE’s DNN (Deep Neural Networks) Training Appliance is an on-premises AI development platform that combines high performance GPU servers and a user-friendly GUI with powerful optimizations to effectively improve the accuracy and reduce the time required for DNN training. Both of the server solutions are for businesses of all sizes to transition effortlessly into 5G, which promises endless possibilities and is the foundation of a new digitally driven industrial revolution featuring an era of Intelligent Connectivity – the convergence of AI, Big Data, and IoT – powered by 5G.
5G and AI to Make a Breakthrough in 2020
According to Deloitte’s market trend report last year, 2020 will be the year for 5G and Artificial Intelligence to take off; and MWC echoes on its website that the market for AI is projected to reach $70 billion by 2020. Intelligent Connectivity is a pivotal evolution of 5G, and Artificial Intelligence is poised to have a transformative effect on consumers, enterprises, and governments around the world.
GIGABYTE demonstrates on [GIGABYTE MWC Online] an eMBB scenario in which higher density, greater performance, and feature-rich computing can help accelerate applications that require increased bandwidth. As an NVIDIA EGX platform builder, GIGABYTE is able to showcase a secure, cloud native edge computing platform for IoT, AI, 3D, XR and beyond, featuring an integrated hardware and software stack which can be used to quickly & easily deploy ready-to-use containers and AI frameworks from NGC (NVIDIA GPU Cloud). And GIGABYTE’s AERO series laptop is the world’s first laptop powered by Microsoft Azure AI. Through machine learning, Azure will assist the AERO laptop to optimize system settings and control CPU & GPU’s power consumption to effectively improve users working environment, and ultimately define what a laptop should perform in the Intelligent Connectivity era of 5G.
Find Your 5G Edge
MEC is a key technology for 5G to come to its full implementation, and GIGABYTE wants to use [GIGABYTE MWC Online] as a portal to share its expert know-how and critical products and solutions, and showcase its data center knowledge that will help you "Find Your 5G Edge" to vindicate its capability to "Upgrade Your Life".
By February 24th , the website will be fully accessible for everyone to explore edge computing and 5G. GIGABYTE has transformed its MWC exhibition into an online experience, including filming marketing and product experts’ short footages to provide insights and share perspectives. Partners and customers who might have hoped to connect with GIGABYTE to discuss 5G possibilities can do so by filling out a short online form, and visitors and users can participate in an online event to learn more about GIGABYTE’s solutions and win an NVMe 1TB SDD.
About GIGABYTE
GIGABYTE is an engineer, visionary, and leader in the world of tech that uses its hardware expertise, patented innovations, and industry leadership to create, inspire and advance. Renowned for over 30 years of award-winning excellence, GIGABYTE is a cornerstone in the HPC community, providing businesses with server and data center expertise to accelerate their success. At the forefront of evolving technology, GIGABYTE is devoted to inventing smart solutions that enable digitalization from edge to cloud, and allow customers to capture, analyze, and transform digital information into economic data that can benefit humanity and "Upgrade Your Life". Please visit https://www.gigabyte.com/ for more information.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200224005042/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom